ArticlePharmaceuticals (Basel, Switzerland)2013

Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy.

Takashi Okada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.